Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $31 | $4 | $0 | $3 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $22 | $4 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $53 | $8 | $1 | $5 |
| Operating Income | -$54 | -$9 | -$1 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $40 | -$52 | $5 | -$11 |
| Pre-Tax Income | -$14 | -$60 | $4 | -$16 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$60 | $4 | -$16 |
| % Margin | – | – | – | – |
| EPS | -0.094 | -0 | 0.037 | -0.33 |
| % Growth | -23,300% | -101.1% | 111.1% | – |
| EPS Diluted | -0.094 | -0 | 0.037 | -0.33 |
| Weighted Avg Shares Out | 147 | 165 | 120 | 48 |
| Weighted Avg Shares Out Dil | 147 | 165 | 120 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$59 | $4 | -$15 |
| % Margin | – | – | – | – |